Click ME to close the menu.

Log In to MTD Channels to access your customer cockpit and see content more relevent to you.

GE to invest €150m to bring 500 jobs to medical manufacturing in Ireland

GE to invest €150m to bring 500 jobs to medical manufacturing in Ireland

Added to MTDCNC by MTDCNC on 29 September 2016

Ireland’s Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor has announced that GE is to invest €150 million in a new biopharmaceutical manufacturing campus at Ringaskiddy, County Cork.  The new facility will feature Europe’s first KUBio™, prefabricated, off-the-shelf bio-manufacturing facilities, owned and run by GE customers.

The new GE BioPark Cork is expected to be home to more than 500 new jobs when fully operational; 400 with biopharma companies and a further 100 employed directly by GE. The construction phase is expected to begin by the middle of 2017 and create up to 800 construction jobs. The new facility will develop bio-manufacturing skills for 1,500 bio-professionals each year.

GE BioPark Cork will be a GE-managed campus including four fully-equipped KUBio factories owned by independent biopharma companies manufacturing proprietary medicines, with GE running centralised shared utilities and site services.

Minister Mitchell O’Connor said: "The Biopharma industry makes a huge contribution to the Irish economy in terms of jobs and manufacturing exports, and is one of the fastest growing sectors. I am delighted that GE is making a significant investment in Cork.  This is a further testament to our talented workforce.  Over 28,000 people currently work in biopharma and 6,000 of those work in biologics. This subsector is expected to double in the coming years and will provide both a challenge and an opportunity for the industry."

Kieran Murphy, CEO, GE Healthcare Life Sciences, GE Healthcare said: “Pharma companies world-wide are racing to respond to patient needs with new life-changing biological medicines and GE is investing in technology and service solutions, as well as industry skills and expertise, to enable them to make and get their products to market more quickly. We are delighted to be investing once again in Ireland, where we have ourselves a long history of manufacturing our own medical imaging products.”

Building Location